Immunic Inc. (IMUX) Tops Q2 EPS by 43c
Tweet
Share
E-mailGet Alerts IMUX Hot Sheet
Join SI Premium – FREE
Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.80), $0.43 better than the analyst estimate of ($1.23).
For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Harvard Bioscience (HBIO) Tops Q2 EPS by 24c ; Offers Guidance
- Patrick Industries (PATK) PT Lowered to $115 at Benchmark on Lower RV Shipment Volumes
- Broadwind Energy (BWEN) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
